Hospital AI Lab Practical information on medical AI for U.S. hospitals

Updated:

Medical technology and research in the United States

What is the United States publishing and testing in medicine right now? This page collects papers whose author affiliations include the United States and drug trials with sites there, all from the last 12 months, in three groups: surgical techniques, new drugs and therapies, and diseases.

Period: 2025-11-16 to 2026-11-16 · updated automatically every week

How to read this page
  • This is an automatic list of titles, journals, dates and links from PubMed and ClinicalTrials.gov. We do not copy abstracts or article text, and we have not checked the findings.
  • A paper or a trial existing is not evidence that a treatment works or is safe, and it is not medical advice. Ask your clinician about any treatment.
  • “Papers from the United States” means at least one author affiliation mentions the country; it does not mean the whole study was done there.
  • Titles are shown in their original language (mostly English).

Surgical techniques

Minimally invasive, robot-assisted, endoscopic, joint replacement and transplant papers.

Showing the latest 12 of 11,250 matches

  1. Colorectal cancers with distinct metastatic potential trigger divergent early T cell responses

    J Exp Med 2026-10-26 Saad M, Thoms A, Yin YS et al. PMID 42929781

  2. Stabilizing breast implants with the double anchor capsule flap technique: insights from a retrospective case series of 30 patients

    JPRAS Open 2026-10-25 Franco Arias DA, Edwards CM, Tomkowski Cancian L et al. PMID 43032105

  3. Trans-endplate delivery of arginine-based poly (ester amide) for structure-preserving therapy of intervertebral disc degeneration

    Bioact Mater 2026-10-22 Ling Z, Guo Q, Tong T et al. PMID 42959279

  4. Hematopoietic cell transplantation using treosulfan-based conditioning for IL-10 receptor deficiency

    J Hum Immun 2026-10-15 Lakkaraja M, Schmitt EG, Sood AK et al. PMID 42878707

  5. Perioperative Risk Assessment and Management in Patients With CKD, Dialysis Dependence, and Kidney Transplantation

    Kidney Int Rep 2026-10-10 Yadlapalli S, Nekkalapudi DK, Wish JB PMID 43032246

  6. Rapid quantification of environmental pollutant metals in dried blood spots via direct microextraction coupled to ICP-MS (μEx-ICP-MS)

    Talanta 2026-09-30 Stouffer CJ, Marcus RK PMID 42826485

  7. Contemporary Arthroscopic Management of Volar and Dorsal Ganglia, Addressing the Problem from Inside-Out

    Hand Clin 2026-09-25 Chambers SB, Wagner ER PMID 43003551

  8. Radical Cystectomy: Perioperative Complications

    Urol Clin North Am 2026-09-21 Hudson C, Nguyen M, Ostergar A et al. PMID 43009231

  9. Comparing outcomes of onlay humeral stem designs in reverse total shoulder arthroplasty: a systematic review

    JSES Rev Rep Tech 2026-09-18 Daher N, Mazeh M, Castle JP et al. PMID 42926853

  10. Nanoparticle-mediated magnetic hyperthermia for ectopic pregnancy treatment

    Biomaterials 2026-09-17 Duraisamy K, Singh P, Vyawahare A et al. PMID 42772082

  11. Complications of Percutaneous Nephrolithotomy

    Urol Clin North Am 2026-09-17 Vaughn CM, Borofsky MS PMID 43009227

  12. Stemmed versus stemless humeral implants in anatomic total shoulder arthroplasty: a systematic review and meta-analysis

    JSES Rev Rep Tech 2026-09-11 Dieu V, Puga TB, Haechten T et al. PMID 42908885

New drugs and therapies (papers)

Phase 1–3 and randomized trials of drugs, antibodies, vaccines and new therapies.

Showing the latest 12 of 2,770 matches

  1. Novel creatine formulation exhibits similar serum creatine concentrations and pharmacokinetics to creatine monohydrate in healthy adults

    J Int Soc Sports Nutr 2026-11-09 DelBiondo GM, Gottlieb CW, Baker PA et al. PMID 43001460

  2. Cost-effectiveness of onabotulinumtoxinA versus topiramate in chronic migraine in the US: an economic analysis of the FORWARD randomized trial

    J Med Econ 2026-11-06 Ronquest N, Zhang Y, Park TJ et al. PMID 42989979

  3. Effects of psilocybin with psychological support on anhedonia in treatment-resistant depression: A randomized controlled pilot trial

    J Affect Disord 2026-10-30 Novick AM, Love TM, Johnson RL et al. PMID 42962721

  4. Sustained Psychosocial Benefits of Telehealth Occupational Therapy for Young Adults With Type 1 Diabetes: Long-Term Follow-Up of the Resilient, Empowered, Active Living-Telehealth (REAL-T) Randomized Controlled Trial

    Sci Diabetes Self Manag Care 2026-10-28 Pyatak EA, Nnoli ND, Mo Y et al. PMID 42952181

  5. Hemagglutinin- and neuraminidase-targeting antibody responses after receipt of egg-based inactivated or recombinant influenza vaccines among adults aged 18-64 years

    Vaccine 2026-10-27 Mishin VP, Patel MC, Gao R et al. PMID 42945702

  6. Phase 2 trial to evaluate the safety and immunogenicity of a 25-valent pneumococcal conjugate vaccine (IVT-PCV25) in infants

    Vaccine 2026-10-21 Bravo L, Bermal N, Alberto E et al. PMID 42906503

  7. Long-term efficacy of lebrikizumab in treating head, neck and face involvement in patients with moderate-to-severe atopic dermatitis

    J Dermatolog Treat 2026-10-19 Chovatiya R, de Bruin-Weller M, Alexis A et al. PMID 42895209

  8. Aberrant amygdala subregion volumes in youth at high risk for bipolar disorder predict antidepressant-induced adverse events

    J Affect Disord 2026-10-16 Tang B, Patino LR, Blom TJ et al. PMID 42887787

  9. Safety and immunogenicity of Thailand Government Pharmaceutical Organization (GPO) produced, COVID-19 vaccine, 10 μg HXP-GPOVac: A Phase III, double-blind, randomized trial in comparison with VAXZEVRIA

    Vaccine 2026-10-13 Prasert K, Nakphook S, Kittiwatanachod J et al. PMID 42869875

  10. Testing peripheral and central therapies for provoked vestibulodynia: results from the UPDATe trial

    Ann Med 2026-10-10 Shudt C, Carey ET, Geller EJ et al. PMID 42857927

  11. Safety, antiviral activity, and pharmacokinetics of long-acting cabotegravir plus long-acting rilpivirine in virologically suppressed adolescents living with HIV-1 (IMPAACT 2017/MOCHA): week 96 and end-of-study results from a multinational, phase 1/2, single-arm trial

    Lancet Child Adolesc Health 2026-10-06 Moore CB, Baltrusaitis K, Capparelli EV et al. PMID 42838065

  12. Participant experiences of stopping ART as part of a clinical trial; findings from a qualitative study within the RIO trial in the United Kingdom

    HIV Res Clin Pract 2026-10-02 Gohil J, Molina M, Ahmed A et al. PMID 42826224

Drug trials started in the last year

Drug studies registered on ClinicalTrials.gov with a site in this country, newest first.

Showing the latest 12 of 3,613 matches

  1. The Study of Brave-LC LDN Treatment Trial

    NCT07916259 Phase: Phase 3 Started: 2026-11-16 Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) Conditions: Post-acute COVID-19 Syndrome Drug / intervention: naltrexone, Placebo

  2. A Phase 1/1b Study of PRT13722 in Participants With Advanced HR+/HER2- Breast Cancer

    NCT07905001 Phase: Phase 1 Started: 2026-11-16 Sponsor: Prelude Therapeutics Incorporated Conditions: Breast Cancer, Hormone-receptor-positive Breast Cancer, HER2-negative Breast Cancer Drug / intervention: PRT13722, Fulvestrant

  3. GLP-1 Plus Lifestyle for Overall Wellness: Find Your Way Forward

    NCT06977438 Phase: Phase 4 Started: 2026-11-15 Sponsor: University of Minnesota Conditions: Obesity, Childhood Drug / intervention: Semaglutide

  4. Measuring Circulating Tumor Deoxyribonucleic Acid Tumor Fraction to Guide Early 177Lu-PSMA-617 Treatment Discontinuation in Patients With Metastatic Castration-Resistant Prostate Cancer, DYNAMO Trial

    NCT07698535 Phase: Phase 2 Started: 2026-11-15 Sponsor: University of Washington Conditions: Metastatic Castration-Resistant Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 Drug / intervention: Lutetium Lu 177 Vipivotide Tetraxetan, Cell-free Circulating Tumor DNA Assay

  5. Circulating Tumor DNA-Informed Adjuvant Therapy for Intermediate-Risk Head and Neck Cancer

    NCT07932067 Phase: Phase 2 Started: 2026-11-15 Sponsor: Kevin Contrera Conditions: Head and Neck Cancer Drug / intervention: Cisplatin or carboplatin, Intensity-modulated radiation therapy (IMRT) or Intensity-modulated proton therapy (IMPT)

  6. Autologous CAR T Cells Targeting GPC3 (RPCAR01) for the Treatment of Advanced or Metastatic GPC3 Expressing Hepatocellular Carcinoma

    NCT06968195 Phase: Phase 1 Started: 2026-11-15 Sponsor: Roswell Park Cancer Institute Conditions: Advanced Hepatocellular Carcinoma, Metastatic Hepatocellular Carcinoma, Recurrent Hepatocellular Carcinoma Drug / intervention: Anti-GPC3-CAR Autologous T Lymphocytes, Biospecimen Collection

  7. Nemtabrutinib and Pembrolizumab for the Treatment of Richter Transformation, Diffuse Large B-cell Lymphoma Subtype

    NCT06863402 Phase: Phase 2 Started: 2026-11-15 Sponsor: Roswell Park Cancer Institute Conditions: Richter Syndrome, Diffuse Large B-Cell Lymphoma, Chronic Lymphocytic Leukemia Drug / intervention: Biospecimen Collection, Bone Marrow Biopsy

  8. Value of Potassium Magnesium Citrate in Preventing and Treating Hypertension in African Americans

    NCT05145309 Phase: Phase 2 Started: 2026-11-15 Sponsor: University of Texas Southwestern Medical Center Conditions: Hypertension Drug / intervention: KMgCit, Placebo

  9. A Study to Assess the Efficacy and Safety of Subcutaneous Induction Therapy With Afimkibart in Participants With Moderately to Severely Active Ulcerative Colitis

    NCT07846683 Phase: Phase 3 Started: 2026-11-15 Sponsor: Hoffmann-La Roche Conditions: Moderately to Severely Active Ulcerative Colitis Drug / intervention: Afimkibart, Placebo

  10. A Study to Evaluate the Safety and Efficacy of AC01 Compared to Placebo in Participants With Chronic Heart Failure

    NCT07584967 Phase: Phase 2 Started: 2026-11-15 Sponsor: AnaCardio AB Conditions: Heart Failure With Reduced Ejection Fraction (HFrEF) Drug / intervention: AC01, Placebo

  11. A Study of SRN-101 Administered Prior to Surgical Resection in Adults With Recurrent High-Grade Glioma.

    NCT07826949 Phase: Phase 1 Started: 2026-11-15 Sponsor: Nicholas Butowski Conditions: Recurrent High-Grade Gliomas, Brain Neoplasm, Glioma Drug / intervention: SRN-101, Blood Specimen Collection

  12. Minoxidil With or Without Low-Level Red-Light Therapy for Improving Chemotherapy-Induced Alopecia in Breast Cancer Patients

    NCT07594678 Phase: Phase 2 Started: 2026-11-15 Sponsor: Ohio State University Comprehensive Cancer Center Conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Drug / intervention: Electronic Health Record Review, Minoxidil

Diseases and population studies

Nationwide cohorts, registries and population-based studies on incidence and prevalence.

Showing the latest 12 of 31,537 matches

  1. Opioid treatment patterns, trajectories, and deprescribing indicators among hospitalised adults in Switzerland, 2020-2024: a multicentre observational cohort study

    Lancet Reg Health Eur 2026-11-06 Rainer M, Gasparovic L, Noseda R et al. PMID 43032797

  2. The rise in prevalence of autoantibodies neutralizing type I interferons reaches a plateau in centenarians

    J Hum Immun 2026-10-27 Mørk N, Jensen JA, Bastard P et al. PMID 42944855

  3. Monitoring of adverse events following 2024-2025 BNT162b2 KP.2 COVID-19 vaccination in the United States

    Vaccine 2026-10-26 Sun JW, Dodge LE, Cai S et al. PMID 42933241

  4. Characterizing hypertension in activated PI3K delta syndrome: Findings from Epic Cosmos

    J Hum Immun 2026-10-26 Santiago B, Keelin J, Sun X et al. PMID 42929758

  5. Incidence of medically attended Lyme borreliosis across endemic regions of six European countries (BOLD): a prospective multicentre active surveillance study

    Lancet Reg Health Eur 2026-10-26 Halsby K, Loew-Baselli A, Moniuszko-Malinowska A et al. PMID 42990948

  6. Emerging Skin and Soft Tissue Infections

    Dermatol Clin 2026-10-23 Mueller K, Williams AS, Drake L et al. PMID 43025936

  7. Prevalence and mortality of chronic extracellular matrix dysregulated diseases: a nationwide register-based study

    Lancet Reg Health Eur 2026-10-23 Christiansen RC, Bager CL, Heinz A et al. PMID 42960173

  8. Liver fibrosis risk, missed follow-up, and inequitable specialist referral in the All of Us Research Program: a retrospective cohort study

    Lancet Reg Health Am 2026-10-19 Sellers K, White TM, Manolas MI et al. PMID 42920888

  9. Temporal trends in radiation-induced optic neuropathy: a meta-analysis

    Clin Transl Radiat Oncol 2026-10-18 Thariat J, Pham TN, Sochacki T et al. PMID 42997473

  10. Primary care effectiveness, multimorbidity, and hospital use in public and private health-care systems in Brazil: a cross-sectional analysis of data from the 2019-2021 Brazilian longitudinal study of aging

    Lancet Reg Health Am 2026-10-17 Oliveira GM, Nunes BP, Lam K et al. PMID 42935795

  11. Suicide mortality and suicide method trends in the Region of the Americas, 2015-2021: a population-based time-series analysis of progress toward a one-third reduction target

    Lancet Reg Health Am 2026-10-15 Lange S, Martinez R, Guo K et al. PMID 42927255

  12. Thyroid Disease in the Era of Obesity and Glucagon-Like-Peptide-1 Agonists

    Otolaryngol Clin North Am 2026-10-14 Coblens O, Dunmire A, Maldonado-Chapa F PMID 42869735

Source: PubMed · ClinicalTrials.gov